Literature DB >> 23831727

Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy.

Foteini Mourkioti1, Jackie Kustan, Peggy Kraft, John W Day, Ming-Ming Zhao, Maria Kost-Alimova, Alexei Protopopov, Ronald A DePinho, Daniel Bernstein, Alan K Meeker, Helen M Blau.   

Abstract

Duchenne muscular dystrophy (DMD), the most common inherited muscular dystrophy of childhood, leads to death due to cardiorespiratory failure. Paradoxically, mdx mice with the same genetic deficiency of dystrophin exhibit minimal cardiac dysfunction, impeding the development of therapies. We postulated that the difference between mdx and DMD might result from differences in telomere lengths in mice and humans. We show here that, like DMD patients, mice that lack dystrophin and have shortened telomeres (mdx/mTR(KO)) develop severe functional cardiac deficits including ventricular dilation, contractile and conductance dysfunction, and accelerated mortality. These cardiac defects are accompanied by telomere erosion, mitochondrial fragmentation and increased oxidative stress. Treatment with antioxidants significantly retards the onset of cardiac dysfunction and death of mdx/mTR(KO) mice. In corroboration, all four of the DMD patients analysed had 45% shorter telomeres in their cardiomyocytes relative to age- and sex-matched controls. We propose that the demands of contraction in the absence of dystrophin coupled with increased oxidative stress conspire to accelerate telomere erosion culminating in cardiac failure and death. These findings provide strong support for a link between telomere length and dystrophin deficiency in the etiology of dilated cardiomyopathy in DMD and suggest preventive interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23831727      PMCID: PMC3774175          DOI: 10.1038/ncb2790

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  58 in total

1.  107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.

Authors:  K Bushby; F Muntoni; J P Bourke
Journal:  Neuromuscul Disord       Date:  2003-02       Impact factor: 4.296

2.  Duchenne muscular dystrophy models show their age.

Authors:  Jeffrey S Chamberlain
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

3.  Treatment of the heart in Duchenne muscular dystrophy.

Authors:  Peter Baxter
Journal:  Dev Med Child Neurol       Date:  2006-03       Impact factor: 5.449

4.  Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.

Authors:  Jachinta E Rooney; Jennifer V Welser; Melissa A Dechert; Nichole L Flintoff-Dye; Stephen J Kaufman; Dean J Burkin
Journal:  J Cell Sci       Date:  2006-05-09       Impact factor: 5.285

Review 5.  Oxidative stress in heart failure: what are we missing?

Authors:  Douglas B Sawyer
Journal:  Am J Med Sci       Date:  2011-08       Impact factor: 2.378

6.  Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Shuxun Ren; E Rene Rodriguez; Barbara Tavazzi; Giuseppe Lazzarino; Nazareno Paolocci; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

7.  Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis.

Authors:  E González-Suárez; E Samper; J M Flores; M A Blasco
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

8.  Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy.

Authors:  A E Deconinck; J A Rafael; J A Skinner; S C Brown; A C Potter; L Metzinger; D J Watt; J G Dickson; J M Tinsley; K E Davies
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.

Authors:  Kwok-Kin Wong; Richard S Maser; Robert M Bachoo; Jayant Menon; Daniel R Carrasco; Yansong Gu; Frederick W Alt; Ronald A DePinho
Journal:  Nature       Date:  2003-01-22       Impact factor: 49.962

10.  Use of tibial length to quantify cardiac hypertrophy: application in the aging rat.

Authors:  F C Yin; H A Spurgeon; K Rakusan; M L Weisfeldt; E G Lakatta
Journal:  Am J Physiol       Date:  1982-12
View more
  60 in total

Review 1.  Targeting Age-Related Pathways in Heart Failure.

Authors:  Haobo Li; Margaret H Hastings; James Rhee; Lena E Trager; Jason D Roh; Anthony Rosenzweig
Journal:  Circ Res       Date:  2020-02-13       Impact factor: 17.367

2.  Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells.

Authors:  John Ramunas; Eduard Yakubov; Jennifer J Brady; Stéphane Y Corbel; Colin Holbrook; Moritz Brandt; Jonathan Stein; Juan G Santiago; John P Cooke; Helen M Blau
Journal:  FASEB J       Date:  2015-01-22       Impact factor: 5.191

3.  Long telomeres protect against age-dependent cardiac disease caused by NOTCH1 haploinsufficiency.

Authors:  Christina V Theodoris; Foteini Mourkioti; Yu Huang; Sanjeev S Ranade; Lei Liu; Helen M Blau; Deepak Srivastava
Journal:  J Clin Invest       Date:  2017-03-27       Impact factor: 14.808

Review 4.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

5.  Profile of Helen M. Blau.

Authors:  Farooq Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-16       Impact factor: 11.205

6.  Evaluation of telomere length in human cardiac tissues using cardiac quantitative FISH.

Authors:  Maryam Sharifi-Sanjani; Alan K Meeker; Foteini Mourkioti
Journal:  Nat Protoc       Date:  2017-08-17       Impact factor: 13.491

7.  Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy.

Authors:  Alex Chia Yu Chang; Sang-Ging Ong; Edward L LaGory; Peggy E Kraft; Amato J Giaccia; Joseph C Wu; Helen M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

8.  Mesenchymal stem cells confer resistance to doxorubicin-induced cardiac senescence by inhibiting microRNA-34a.

Authors:  Wenzheng Xia; Meng Hou
Journal:  Oncol Lett       Date:  2018-04-23       Impact factor: 2.967

9.  Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy.

Authors:  Yongping Yue; Ibrahim M Binalsheikh; Stacey B Leach; Timothy L Domeier; Dongsheng Duan
Journal:  Expert Opin Orphan Drugs       Date:  2015-12-17       Impact factor: 0.694

10.  Nanopatterned Human iPSC-based Model of a Dystrophin-Null Cardiomyopathic Phenotype.

Authors:  Jesse Macadangdang; Xuan Guan; Alec S T Smith; Rachel Lucero; Stefan Czerniecki; Martin K Childers; David L Mack; Deok-Ho Kim
Journal:  Cell Mol Bioeng       Date:  2015-09       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.